iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionAE Wealth Management LLC
Latest Disclosed Ownership1,812 shares
Latest Disclosed Value $ 305,960
AE Wealth Management LLC ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 13, 2026 - AE Wealth Management LLC filed a 13F-HR form disclosing ownership of 1,812 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $305,960 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 1,516 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 19.53% during the quarter. The current value of the position is $237,463 USD.

AE Wealth Management LLC has a history of taking positions in derivatives of the underlying security (0JGB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JGB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,812 296 19.53 306 19.61 0.0000
2026-01-26 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,516 118 8.44 256 26.87 0.0015
2025-11-03 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,398 -203 -12.68 202 -0.50 0.0013
2025-08-06 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,601 -410 -20.39 203 -21.40 0.0015
2025-05-06 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,011 -137 -6.38 257 -9.51 0.0022
2025-02-13 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,148 -98 -4.36 284 -13.15 0.0024
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,246 212 10.42 327 17.20 0.0030
2024-08-12 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,034 196 10.66 279 10.71 0.0028
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,838 -23,270 -92.68 252 -92.58 0.0029
2024-02-14 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 25,108 2,215 9.68 3,398 21.40 0.0174
2023-10-11 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 22,893 3,467 17.85 2,800 13.50 0.0167
2023-07-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 19,426 -1,486 -7.11 2,466 -8.70 0.0148
2023-04-14 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 20,912 -3,610 -14.72 2,701 -16.09 0.0174
2023-01-31 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 24,522 -3,078 -11.15 3,219 -0.28 0.0233
2022-10-25 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 27,600 5,698 26.02 3,228 25.31 0.0256
2022-08-03 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 21,902 1,507 7.39 2,576 -3.09 0.0206
2022-04-18 2022-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 20,395 1,463 7.73 2,658 -8.00 0.0182
2022-01-20 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 18,932 9,099 92.54 2,889 81.70 0.0201
2021-11-01 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,833 -754 -7.12 1,590 -8.20 0.0131
2021-07-21 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,587 38 0.36 1,732 9.07 0.0151
2021-04-27 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 10,549 1 0.01 1,588 -0.63 0.0160
2021-02-01 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 10,548 -30 -0.28 1,598 11.59 0.0181
2020-11-06 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 10,578 -9,537 -47.41 1,432 -47.91 0.0204
2020-08-05 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 20,115 -38,492 -65.68 2,749 -56.46 0.0425
2020-05-07 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 58,607 45,780 356.90 6,314 308.41 0.1451
2020-01-15 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 12,827 539 4.39 1,546 26.41 0.0335
2019-11-05 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 12,288 -1,466 -10.66 1,223 -18.52 0.0353
2019-07-22 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 13,754 8,155 145.65 1,501 139.78 0.0451
2019-05-14 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,599 -3,274 -36.90 626 -26.87 0.0435
2019-02-14 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 8,873 -3,092 -25.84 856 -41.33 0.1465
2018-11-13 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 11,965 6,460 117.35 1,459 141.16 0.0803
2018-08-14 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 5,505 186 3.50 605 6.51 0.0412
2018-05-14 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,319 3,346 169.59 568 169.19 0.0438
2018-02-06 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,973 763 63.06 211 -47.77 0.0186
2017-11-08 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,210 316 35.35 404 45.85 0.0375
2017-08-11 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 894 894 277 0.0331
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-11-05 2019-09-30 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-07-22 2019-06-30 13F ISHARES TR NASDAQ BIOTECH Call 800 2 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.